NEW YORK, June 6, 2011
/PRNewswire/ -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) today
announced that their June 2nd
RetailInvestorConferences.com presentation is available for
on-demand viewing.
LINK: www.retailinvestorconferences.com> Click the red
"register/ watch event now" button.
Aeolus Pharmaceuticals' presentation will be available for 90
days. Investors may download shareholder materials from the
"virtual trade booth" for the next three weeks.
About Aeolus Pharmaceuticals
Aeolus Pharmaceuticals is developing a new class of catalytic
antioxidant compounds that protects healthy tissue from the
damaging effects of radiation. Its first compound, AEOL 10150, is
being developed for oncology indications, where it is used in
combination with radiation therapy. It is also being developed,
with up to $140 million in funding by
the US Government, as a medical countermeasure against chemical and
radiological weapons, where its initial target indications are as a
protective agent against the effects of acute radiation syndrome
and delayed effects of acute radiation exposure. Aeolus' strategy
is to leverage the substantial investment in toxicology,
manufacturing, and preclinical and clinical studies made by US
Government agencies in AEOL 10150 to efficiently develop the
compound for use in oncology.
About RetailInvestorConferences.com:
RetailInvestorConferences.com, created by BetterInvesting
(NAIC),PR Newswire and MUNCmedia, is the first monthly
virtual investor conference series that provides an interactive
forum for presenting companies to meet directly with retail
investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based
investor conferences, Retail Investor Conferences unites PR
Newswire's leading-edge online conferencing and investor
communications capabilities with BetterInvesting's extensive retail
investor audience network and MUNCmedia's sophisticated retail
investor targeting.
SOURCE Aeolus Pharmaceuticals